Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$0.67 - $3.19 $13,400 - $63,800
-20,000 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$2.36 - $3.57 $47,200 - $71,400
20,000 New
20,000 $53,000
Q4 2018

Feb 14, 2019

SELL
$2.08 - $3.36 $56,160 - $90,720
-27,000 Closed
0 $0
Q3 2018

Nov 09, 2018

BUY
$2.6 - $3.59 $70,200 - $96,930
27,000 New
27,000 $87,000

Others Institutions Holding RIGL

About RIGEL PHARMACEUTICALS INC


  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $1.46B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track Marco Investment Management LLC Portfolio

Follow Marco Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marco Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marco Investment Management LLC with notifications on news.